From: Biomarkers of inflammation and innate immunity in atrophic nonunion fracture
 | HV | NU | P values |
---|---|---|---|
n | 35 | 33 | Â |
Age [median (range)] | 32 (23–78) | 44 (18–78) | 0.004 |
Sexe (% of female) | 62Â % | 31Â % | 0.003 |
BMI [median (range)] | 26.1 (20.5–31.1) | 26.8 (18.8–37.1) | NS |
Smokers | 28Â % | 58Â % | 0.03 |
Daily alcohol | 0Â % | 29Â % | 0.003 |
Comorbidities | |||
Fracture history in the past year of visit | 6Â % | 100Â % | <0.001 |
Rheumatic diseases (osteoarthritis, psoriatic arthritis and rheumatoid arthritis) | 0Â % | 14Â % | NS |
Gastric (heartburn and esophagitis) | 0Â % | 14Â % | NS |
Diabetes (NIDDM) | 0Â % | 10Â % | NS |
Pulmonary (asthma, emphysema, chronic pulmonary disease, pneumothorax) | 0Â % | 24Â % | 0.006 |
Cardiovascular (ischaemia, deep vein thrombosis, infarction) | 0Â % | 14Â % | NS |
High blood pressure | 0Â % | 17Â % | NS |
Hypercholesterolemia | 0Â % | 17Â % | NS |
Hypothyroidism | 0Â % | 0Â % | NS |
Hypovitamin D | 0Â % | 3Â % | NS |
Treatment | |||
NSAID and/or analgesic and/or tramadol | 0Â % | 100Â % | <0.001 |
Anxiolytics | 0Â % | 33Â % | <0.001 |